Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-539-3 | CAS number: 62-53-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- short-term repeated dose toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study comparable to guideline study. Only male animals were tested. Histopathology performed at day 3 post exposure to a limited number of organs (spleen, femur, sternum, liver, lung).
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 004
- Report date:
- 2004
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 004
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 412 (Subacute Inhalation Toxicity: 28-Day Study)
- Version / remarks:
- 14-day study
- Deviations:
- yes
- Remarks:
- Only male animals were used. Histopathology performed at day 3 post exposure in selected organs (spleen, femur, sternum, liver, lung)
- Principles of method if other than guideline:
- The study was performed on male rats exposed to aniline vapor over a period of two weeks (Day 0 - 11, nose-only, 6 hours/day, 5 days/week) followed by a two-week postexposure observation period. On days 0, 4, 11, 14, and 28 serial sacrifices were performed for examinations related to hematotoxicity.
- GLP compliance:
- yes
Test material
- Reference substance name:
- Aniline
- EC Number:
- 200-539-3
- EC Name:
- Aniline
- Cas Number:
- 62-53-3
- Molecular formula:
- C6H7N
- IUPAC Name:
- aniline
- Details on test material:
- Supplier: Merck, Darmstadt
Catalog no.: 822256
Puritiy: >99% (according to supplier)
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Specific-pathogen-free Wistar rats of the strain Hsd Cpb:WU (SPF) were from the experimental animal breeder Harlan-Winkelmann GmbH, Borchen, Germany.
At the commencement of the study the rats were approximately 2–3 months old and their average body weight was 240 g. All animals were housed individually in polycarbonate cages containing bedding material (low-dust wood shavings) and were provided with a standard fixed-formula diet
(KLIBA 3883 pellets maintenance diet for rats and mice; PROVIMI KLIBA SA, 4303 Kaiseraugst, Switzerland) and municipality tap water in drinking bottles. Feed and water was available ad libitum except during exposure. Animals were acclimated to the housing conditions (12-h light/dark cycle, temperature about 22°C, relative humidity 40%–60%) for at least 5 days prior to initiation of exposure to the test material.
Administration / exposure
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- nose only
- Vehicle:
- other: unchanged (no vehicle)
- Details on inhalation exposure:
- Vapor atmospheres of aniline were generated under dynamic conditions using a bubbler containing liquid aniline (measures of bubbler: diameter: about 2 cm in the 10, 30, and 90 mg/m3 groups and 4.5 cm in the 270 mg/m3, height of liquid level: about 5 cm). These bubblers were maintained at 25°C with a digitally controlled thermostat. Air flows passed through the liquid aniline were controlled digitally by calibrated mass flow controllers
and ranged from 0.12l/min to 3.4l/min in the low and high group, respectively. This atmosphere was subsequently diluted by conditioned,
dry air. The total flow rate directed into the nose-only exposure chamber was 30 l/min.
Rats of the control group were exposed nose-only to dry, filtered air only.
The inhalation chamber had a volume of 7.6 l and was suitable to accommodate 40 rats. The air flow rate supplied into and extracted from the chamber provided a slight positive balance of air flow toward the rats’ breathing zone, and was maintained at 0.75 l/min/exposure port. - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Exposure atmospheres were characterized by using a gas chromatographic technique (Hewlett-Packard GC 5890 equipped with a flame ionization
detector, split/splitless injector capillary column HPUltra 50+, length: 30 m, ID: 0.32 mm, film thickness 0.17 mm, autosampler HP 7673, and an HP 3365 Work-Station for data processing). For GC analyses, samples were taken from the vicinity of the rats’ breathing zone three times per exposure day using two impingers (in-line) filled with toluene. Between the glass bubblers and the gas-metering device (digital flow controller) a cool-trap was used to scrub volatile constituents from the sampled air. For calibrations, the test substance served as reference material. The sampling flow rate was 0.5 l/min. The sample volumes were 50, 20, 10, and 10 l/sample in the 10, 30, 90, and 270 mg/m3 group, respectively. In the last two groups, the temporal stability of concentrations of aniline in the chambers was monitored continuously using a Compur Total Hydrocarbon Analyzer (Compur, Munich, Germany). Chamber temperature and humidity were measured electronically, and mean values were approximately 23°C and 55%, respectively. - Duration of treatment / exposure:
- 6h/day head-only to aniline vapor
- Frequency of treatment:
- 5 days/week for 14 days followed by a post-exposure period up to 28 days.
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
10, 30, 90, and 270 mg/m3
Basis:
nominal conc.
- Remarks:
- Doses / Concentrations:
9.2, 32.4, 96.5, and 274.9 mg/m3
Basis:
analytical conc.
- No. of animals per sex per dose:
- 30
- Control animals:
- yes
- Details on study design:
- Although female rats are often shown to be more susceptible to the formation of MetHb and the development of anemia than male rats, this study utilized male rats only to allow a better comparison with existing mechanistic studies.
Male Wistar rats were exposed nose only to aniline vapor in targeted concentrations of 10, 30, 90, and270 mg/m3 for 6h/day, 5days/week for 2 weeks (days 0–11), followed by a 2-week post-exposure period (up to day 28).
The control group was exposed to conditioned, dry air under otherwise identical conditions.
Serial sacrifices for specialized examinations were performed on days 0, 4, 11, 14, and 28 to address the time-course and reversibility of changes.
The selection of specific endpoints considered publications of previous studies with aniline and its structural analogs
Examinations
- Observations and examinations performed and frequency:
- Observations were reported to be performed according to OECD Guideline 412. Clinical examinations (hematology and clinical biochemistry) were selected according to the known mode of action of the test substance.
- Sacrifice and pathology:
- All animals were euthanized by complete exsanguination (heart puncture) after intraperitoneal sodium-pentobarbital injection (Narcoren, Merial GmbH, Hallbergmoos, Germany). All rats were given a gross-pathological examination.
Weights were recorded for brain, liver, lung, spleen, and testes at interim sacrifices (days 0, 4, and 11) and, in addition, heart, kidneys, and thymus at post-exposure sacrifices (days 14/15 and 28). For the heart, kidneys, and thymus no appreciable time-related effects were expected to occur. Therefore, the weights of these organs were determined only at the time points where the maximum effect, including reversibility, can be evaluated.
From the additional 5 rats/group that were sacrificed on day 15, selected organs and tissues (spleen, femur, sternum, liver, lung) were preserved in 10% neutral-buffered formalin or Davidson’s solution (testes) for histopathology. The lung was intratracheally instilled with the fixative under 20 cm H2O pressure. Osseous tissues were first decalcified and then, as for all other organs, embedded in Paraplast. All slides were stained with hematoxylin and eosin (H&E).
For a better appreciation of the degree of hemosiderosis, a specific iron stain (Prussian blue stain according to Perls) was prepared for formol-fixed sections of the liver and spleen. - Other examinations:
- MetHb: During the exposure period, MetHb was determined during the exposure period from blood obtained from the retroorbital sinus immediately after cessation of exposure as well as during the post exposure period.
Erythrocytes with Heinz bodies was determined on day 0, 4, 11, 14, and 28.
In liver homogenates the following endpoints were determined in 5 rats/group at post-exposure period sacrifices (days 14 and 28):
aminopyrin-N-demethylase (N-DEM),
p-nitroanisol-N-demethylase (O-DEM),
cytochrome P450 (P450),
triglycerides, and total iron (at all sacrifices).
In spleen homogenates the following endpoints were determined in 5 rats/group at all sacrifices: glutathione peroxidase (GPx), lipid peroxidation (LPO), total iron, and ferritin. - Statistics:
- Body weights, hematology, and clinical pathology data were compared using either
(1) the Kruskal-Wallis test and the adjusted U-test or adjusted Welsh-test as the post hoc test or
(2) one-way analysis of variance (ANOVA) and the Dunnett test as the post hoc tests for nonparametric and parametric analyses, respectively (SAS 6.12-routines).
Specialized endpoints (GPx, ferritin, iron) were analyzed with one-way ANOVA and the Tukey-Kramer post hoc test (BCTIC).
Histopathological findings were compared with the concurrent control using Fisher’s exact test.
The proportion of erythrocytes with Heinz bodies was transformed prior to ANOVA analysis using the arcsine square root function. This is appropriate for percentages and proportions, because the transformed data more closely approximate a normal distribution than the non-transformed proportions.
Transformed data were analyzed separately for normality of distribution. For all tests, the criterion for statistical significance was set at p < 0.05.
Results and discussion
Effect levels
open allclose all
- Dose descriptor:
- NOAEC
- Effect level:
- 9.2 mg/m³ air (analytical)
- Dose descriptor:
- LOAEC
- Effect level:
- 32.6 mg/m³ air (analytical)
- Basis for effect level:
- other: slight increase in extramedullary hematopoiesis; this concentration is considered NOAEC for erythrotoxicity, iron accumulation and lipid peroxidation
- Dose descriptor:
- conc. level:
- Effect level:
- >= 96.7 mg/m³ air (analytical)
- Basis for effect level:
- other: clinical signs, body weight reduced, spleen weight and Met-Hb value increased, histopathological effects
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
OBSERVATIONS
All animals survived the duration of study. Concentrations up to and including 30 mg/m3 were tolerated without clinical signs.
Rats exposed to 90 mg/m3 and above were cyanotic (blue discoloration of the skin in areas easily observed), whereas those exposed to 270 mg/m3 also displayed tachypnea, labored breathing patterns, increased salivation, and an ungroomed hair-coat. All signs disappeared toward the following day and did not show any exacerbation during the course of the study. Rectal temperatures measured shortly after cessation of exposure on days 0, 4, and 11 were at all time points indistinguishable among the groups (range of means in the control group: 37.3°–38.6°C, aniline exposure groups: 36.6°–38.4°C).
Body weights were not statistically significantly affected in any group during the course of the study.
The weights of liver (Table 3), brain, lung, testes, heart, kidneys, and thymus did not show treatment-related effects (data not shown). Absolute and relative spleen weights were significantly increased in a time and dose dependent matter. In the group treated with 270 mg aniline/m3 maximum increase of 2.2 fold over the spleen weights of the control (day 11) was observed.
Gross necropsy findings of rats exposed to 90 mg/m3 and above provided evidence of dark discolorations and enlargement of
spleens at all sacrifices beyond the first exposure week.
Some discoloration of lungs was found; however, no consistent time dependence or concentration-dependence existed. An increased incidence of discoloration of the thymus, including involution, and of the testes occurred at 270 mg/m3 (days 11 and 14).
HEMATOLOGY
Hematological parameters were significantly affected at 90 and 270 mg/m3 starting on day 4, with maximum effects on days 11 and 14. They were characterized by a decrease up to 16% in hemoglobin (Hb), red blood cell count (RBC, up to 24%), and hematocrit (HCT, up to 20%), and an increase in reticulocyte counts (RC, up to 6.3fold over control) and erythrocytes containing Heinz bodies (day 4: high dose. 513/1000 cells vs 0/1000 in the control group; day 14: high dose. 266/1000 cells vs 0/1000 in the control group).
The RC observed in controls on day 0 (56/1000) were twice as high as those observed at the subsequent time points. This change might be attributable to the immobilization stress caused by restraint of non-acclimatized rats to exposure tubes and the associated increased discharge of mature reticulocytes from the bone marrow.
On day 11 only rats exposed to 270 mg/m3 showed a significantly increased mean corpuscular hemoglobin (MCH, 1.1 fold over control) and mean corpuscular volume (MCV, 1.2 fold). Furthermore, on day 11 the red blood cells in some rats exhibited hypochromia and anisocytosis.
With regard to the time-course, the hematological changes were maximal on the last exposure day (day 11) and showed some decrease in magnitude on the third post-exposure day (day 14); then, with the exception of the RBC, MCH, and MCHC, hematological changes subsided to the levels of the control group after the 2 week post-exposure.
Thrombocytes were mildly, although significantly increased at the end of the 2-week exposure period (data not shown). Conclusive changes in the total leukocyte counts and leukocyte differentials did not occur at any time point (data not shown).
In the blood sampled and determined immediately after cessation of exposure, MetHb was concentration-dependent, and then was significantly increased at 90 mg/m3 (days 4 and 11, up to approx. 2.5% vs. approx 1% in the control group) and at 270 mg/m3 (days 0, 4, 11, up to approx. 14% vs. approx. 1% in the control group). The MetHb concentrations from blood samples taken in the post-exposure period were indistinguishable from the control.
CLINICAL CHEMISTRY
Data generated on the clinical chemistry focused on potential hepatotoxicity and erythrocyte (hemoglobin) catabolism by the end of the exposure and post-exposure periods. Statistical comparisons did not reveal any consistent concentration–response relationship considered to be of pathodiagnostic relevance except slightly altered bilirubin serum concentrations at 90 and 270 mg/m3. Bilirubin concentration was increased dose dependent on day 14 (up to 1.4 fold over control) and dose dependently decreased by the end of the post-exposure period (up to 40%).
Some electrolytes (calcium, magnesium) were statistically significantly decreased at 30 mg/m3 and above, especially at the end of the post-exposure period. Because of the lack of a clear dose-dependence from 30 to 270 mg/m3 - in comparison to the control and 10 mg/m3 groups - these changes are considered without biological significance. They are considered to be secondary to changes in the concentrations of negatively charged
counterions (anion gap), such as plasma proteins or bicarbonate, rather than reflecting any specific, aniline-induced disturbance in electrolyte homeostasis.
A concentration-dependent and time-dependent increase in the total splenic iron content were observed in rats exposed to 90 and 270 mg/m3, when compared to the controls. Rhe increase in total iron and splenomegaly are related. In contrast, the maximum iron content in liver tissue homogenates was transient, and a slight increase was observed at 270 mg/m3 only. Based on a gram tissue level comparison, the maximum accumulation of iron in the liver and spleen exceeded the control levels by approx. 60% and approx. 500%, respectively.
Lipid peroxidation, measured as the sum of malondialdehyde and 4-hydroxy-2(E)-nonenal, was significantly increased at 90 and
270 mg/m3 three to four-fold over the control group. Despite the marked increase in lipid peroxidationfrom exposure day 0 to exposure day 4, a time-dependent progression between the later exposure days was not apparent. Changes subsided toward the level of the control group at the end of the post-exposure period, i.e., the aniline exposure groups were indistinguishable from the control. During the exposure period, the increase of splenic lipid peroxidation and total iron was highly correlated (r2 = 0.93), whereas this high degree of correlation ceased to exist at the end of the post-exposure period.
The determination of ferritin and glutathione peroxidase (GPx) in the tissue homogenates of the spleen did not attain statistical significance, when compared with the respective controls. However, despite the lack of any consistent concentration-dependence or time-dependence, GPx activity showed a tendency toward increase at the high exposure level.
HISTOPATHOLOGY
In the rats sacrificed on day 15 changes in the spleen at 30 mg/m3 and above and in the liver at 270 mg/m3 were observed.
The most striking morphological changes were observed in the spleen at 90 and 270 mg/m3 and included vascular congestion and splenic hemosiderin pigmentation. A concentration-dependent increased iron deposition was also observed (iron-positive stains). Extramedullary hematopoiesis in the spleen was observed at 30 mg/m3. Lesions indicative of specific splenic tissue damage were not observed.
Liver sections stained with the iron-positive stain showed increased hemosiderosis, which gained statistical significance in the 270 mg/m3 exposure group.
Bone marrow changes indicative of increased medullary hematopoiesis were seen in the histological sections of femur in rats exposed to 270 mg/m3 (evidenced by a decrease in marrow adipocytes).
Spontaneous findings in the remaining tissues examined, including the lung, did not show any relation to exposure to aniline.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)